Ultrasound-Activated PROTAC Prodrugs Overcome Immunosuppression to Actuate Efficient Deep-Tissue Sono-Immunotherapy in Orthotopic Pancreatic Tumor Mouse Models.

The degradation of oncoproteins mediated by proteolysis-targeting chimera (PROTAC) has emerged as a potent strategy in cancer therapy. However, the clinical application of PROTACs is hampered by challenges such as poor water solubility and off-target adverse effects. Herein, we present an ultrasound (US)-activatable PROTAC prodrug termed NPCe6+PRO for actuating efficient sono-immunotherapy in a spatiotemporally controllable manner. Specifically, US irradiation, which exhibits deep-tissue penetration capability, results in Ce6-mediated generation of ROS, facilitating sonodynamic therapy (SDT) and inducing immunogenic cell death (ICD). Simultaneously, the generated ROS cleaves the thioketal (TK) linker through a ROS-responsive mechanism, realizing the on-demand activation of the PROTAC prodrug in deep tissues. This prodrug activation results in the degradation of the target protein BRD4, while simultaneously reversing the upregulation of PD-L1 expression associated with the SDT process. In the orthotopic mouse model of pancreatic tumors, NPCe6+PRO effectively suppressed tumor growth in conjunction with US stimulation.

An Investigation of PPy@1T/2H MoS2 Composites with Durable Photothermal-Promoted Effect in Photo-Fenton Degradation of Methylene Blue and in Water Evaporation.

MoS2 has garnered considerable attention as an exceptional co-catalyst that is capable of significantly enhancing the efficiency of H2O2 decomposition in advanced oxidation processes (AOPs). This improvement allows for a reduction in the required amounts of H2O2 and Fe2+. In this study, we investigated the cyclic durability of photo-Fenton catalysts, focusing on the degradation of pollutants through the introduction of PPy into heterogeneous 1T-2H MoS2 units. The resulting photothermal-Fenton catalysts, comprising non-ferrous Fenton catalysts, demonstrated excellent degradation performance for simulated pollutants. In comparison with 1T-2H MoS2, the PPy@1T-2H MoS2 composite exhibited remarkable stability and photothermal enhancement in the photo-Fenton degradation of methylene blue (MB) under visible light irradiation. The photo-Fenton reaction efficiently degraded contaminants, achieving 99% removal within 5 min and 99.8% removal within 30 min. Moreover, the co-catalyst complex displayed enhanced cyclic stability during the photo-Fenton reaction, with a contaminant removal efficiency of 92%, even after the 13th cyclic test. The combined effects of PPy and 1T-2H MoS2 demonstrated improved efficiency in both photocatalytic and photo-Fenton catalytic reactions. Furthermore, PPy@1T-2H MoS2 exhibited outstanding performance in the photothermal evaporation of water, achieving an efficiency of 86.3% under one solar irradiation.

Synthesis of Hollow N,P-Doped Carbon/Co2P2O7 Nanotubular Crystals as an Effective Electrocatalyst for the Oxygen Reduction Reaction.

Herein, N,P-rich carbon/carbon/Co2P2O7 hollow nanotubes with a multilayered wall structure were successfully fabricated for the ORR electrocatalyst. The hollow tube structure catalysts were obtained by carbonizing Co2P2O7/C coated with the phytate-doped PANI. The Co2P2O7/C was obtained by phosphorylating a basic cobalt carbonate with phytic acid (PA). Onset and positive half-wave potentials were measured at 0.90 and 0.84 V, respectively, with a diffusion-limited current density of 4.58 mA/cm2. Effect of the thickness of polyaniline (PANI) in the electrocatalyst precursor was also investigated. The specific surface area as well as the content of graphitic N altered as the time of PANI polymerization increased, resulting in remarkably different catalytic activities. This study of hollow nanotube catalysts exhibits efficient noble-metal-free oxygen reduction reaction electrocatalysts for other chemical systems, which will provide abundant electrochemical active centers and sufficient energy.

Image-Guided TME-Improving Nano-Platform for Ca2+ Signal Disturbance and Enhanced Tumor PDT.

Dysfunction of the calcium balancing system and disruption of calcium distribution can induce abnormal intracellular calcium overload, further causing serious damage and even cell death, which provides a potential therapeutic approach for tumor treatment. Herein, a nano-platform, which includes UCNPs-Ce6@RuR@mSiO2 @PL-HA NPs (UCRSPH) and SA-CaO2 nanoparticles, is prepared for improving the tumor micro-environment (TME), Ca2+ signal disturbance as well as enhanced photodynamic tumor therapy (PDT). UCRSPH combined with SA-CaO2 can alter TME and relieve hypoxia of the tumor to realize self-reinforcing PDT under near-IR irradiation (980 nm). The ruthenium red (RuR) in the UCRSPH NPs can be released to the cytoplasm after endocytosis of the nanoparticles, target Ca2+ channel proteins on the endoplasmic reticulum and mitochondria, sarcoplasmic reticulum Ca2+ -ATPase (SERCA), and mitochondrial calcium uniporter (MCU). The combined participation of nanoparticles and RuR promotes Ca2+ imbalance and cytoplasmic calcium overload with the assistance of CaO2 , and provides tumor cells higher sensitivity to PDT. Furthermore, the nano-platform also provides fluorescence imaging and calcification computed tomography imaging for in vivo treatment guidance. In conclusion, this image-guided nano-platform show potential for highly specific, efficient combined therapy against tumor cells with minimal side-effects to normal cells by integrating TME improvement, self-reinforcing PDT, and Ca2+ signal disturbance.

A NO/ROS/RNS cascaded-releasing nano-platform for gas/PDT/PTT/immunotherapy of tumors.

Nitric oxide (NO) gas treatment offers a promising strategy for tumor therapy; however, its practical application is still limited due to its poor efficacy and biotoxicity which were caused by gas leakage during blood delivery. Herein, a nano-platform (CMH-OBN) composed of chlorin e6-melanin-hyaluronic acid nanoparticles (Ce6-MNP-HA, CMH) and oxidized bletilla striata polysaccharide microcapsules (Oxi-BSP) carrying NO donors was prepared for responsive and cascaded release of NO, reactive oxygen species (ROS) and its secondary metabolite reactive nitrogen species (RNS) in tumor sites. Melanin not only endowed CMH with good photothermal properties, but also helped Ce6 to produce a large number of ROS under near-infrared (NIR) irradiation. OBN microcapsules, which were sensitive to ROS, can release NO donors under the stimulation of ROS released by CMH nanoparticles under NIR irradiation and can further release NO in the tumor microenvironment (TME) with high expression of glutathione (GSH). NO could further up-regulate soluble guanylate cyclase-cyclic guanosine monophosphate (sGC-cGMP) signal pathways to relieve hypoxia, thus further enhancing the photodynamic therapy (PDT). Moreover, the cascaded release of ROS and NO could produce RNS with higher lethality, which could sequentially initiate the cellular apoptotic procedure and promote immunotherapy by activating T cells at the tumor sites. More interestingly, the CMH-OBN nano-platform could supply magnetic resonance imaging (MRI) and infrared photothermal imaging guidance for tumor therapy. In conclusion, the development of a CMH-OBN nano-platform provides a satisfactory demonstration by combining NO therapy with photothermal therapy (PTT), PDT and immunotherapy for the treatment of cancer.